Nanocrystals, a New Tool to Study Lipoprotein Metabolism and Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|2|365-372

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.2, 2012-02, pp. : 365-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New pharmacological agents under clinical investigation for treating disorders of lipoprotein regulation leading to atherosclerosis

By Gallup E.   Dujovne C.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 3, 2001-03 ,pp. : 561-567

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy in Disorders of Lipoprotein Metabolism

By  

Current Gene Therapy, Vol. 7, Iss. 1, 2007-02 ,pp. : 35-47

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the study of drug nanocrystals

By Shi Jing   Guo Fei   Zheng Aiping   Zhang Xiaoyan   Sun Jianxu  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 12, 2015-12 ,pp. : 757-764

Govi-Verlag

Access to resources Recommend Favorite

Effects on Coronary Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol with Statins

By Ferrières Jean  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 2, 2009-01 ,pp. : 109-115

Adis International

Access to resources Recommend Favorite

Lipoprotein Size and Susceptibility to Atherosclerosis — Insights from Genetically Modified Mouse Models

By  

Current Drug Targets, Vol. 9, Iss. 3, 2008-03 ,pp. : 174-189

Bentham Science Publishers

Access to resources Recommend Favorite